Home›Umeclidinium Bromide And Vilanterol Trifenatate›Umeclidinium Bromide And Vilanterol Trifenatate + Nonselective Beta Adrenergic Antagonists

Does Umeclidinium Bromide And Vilanterol Trifenatate Interact with Nonselective Beta Adrenergic Antagonists?

Umeclidinium Bromide And Vilanterol Trifenatate and Nonselective Beta Adrenergic Antagonists have a major drug interaction according to U.S. FDA drug labeling data. May block bronchodilatory effects of vilanterol and produce severe bronchospasm in COPD patients. Avoid use; if necessary, use cardioselective beta-blockers with caution. The mechanism involves beta-adrenergic receptor blockade antagonizes beta-agonist bronchodilation. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Major
Management
Close medical supervision required
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Umeclidinium Bromide And Vilanterol Trifenatate and Nonselective Beta Adrenergic Antagonists occurs because beta-adrenergic receptor blockade antagonizes beta-agonist bronchodilation. Clinically, this means may block bronchodilatory effects of vilanterol and produce severe bronchospasm in copd patients. avoid use; if necessary, use cardioselective beta-blockers with caution. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.

What To Tell Your Doctor or Pharmacist

If you are taking Umeclidinium Bromide And Vilanterol Trifenatate and your doctor is considering prescribing Nonselective Beta Adrenergic Antagonists (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask how frequently you should be monitored while these are co-prescribed
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Umeclidinium Bromide And Vilanterol Trifenatate(Umeclidinium And Vilanterol Ellipta)+💊 Nonselective Beta Adrenergic Antagonists

Severity & Interaction Details

⚠️
major
Use with caution — major interaction
Serious risk of clinically significant harm. Generally avoid; if used, monitor closely.
Severity scale
MinorContra
On record
Yes
Drug A class
—
Drug B class
—
Source
NLP:umeclidinium bromide and vilanterol trifenatate

What this means in plain English

May block bronchodilatory effects of vilanterol and produce severe bronchospasm in COPD patients. Avoid use; if necessary, use cardioselective beta-blockers with caution.

What the FDA label says

"Beta-adrenergic receptor blockade antagonizes beta-agonist bronchodilation"

📖 Source: NLP:umeclidinium bromide and vilanterol trifenatate

Share this result:XFacebookWhatsAppReddit
Add more drugs
Check Umeclidinium Bromide And Vilanterol Trifenatate and Nonselective Beta Adrenergic Antagonists against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.